Other Industry News

San Francisco's Sinovas Starts $75 Million China VC Fund

Sanovas, a Bay-Area medical device maker, will start a venture capital fund in Suzhou's BioBaypark, which will invest "upwards" of $75 million in Suzhou technologies. Sanovas makes innovati... Full Story

IBM grows Baheal deal to bring Watson genomics to China

IBM and Baheal Pharmaceutical have moved quickly to expand their relationship. Weeks after IBM gave Baheal a starring role in selling its Watson for Oncology product in China, Big Blue has penned a simil... Full Story

Shanghai ChemPartner Plans Reverse Merger with China's Quantum

ShangPharma will merge its Shanghai ChemPartner division, which includes all of the company's CRO/CMO operations, into Quantum Hi-Tech China Biological. The transaction, a reverse merger, allows Chem... Full Story

Resverlogix Closes $10 Million of Equity Subscriptions

today closed its previously-announced offering, issuing a total of $10 million of its equity units. Eastern Capital Limited ("Eastern") and Shenzhen Hepalink Pharmaceutical Co., Ltd. (... Full Story

Zecotek Receives Notice of Allowance in China for New Advanced Formulation of its Worldwide Patented LFS Scintillation Crystal

, a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that its wholly owned division, Zecotek Imaging Systems Pte. Ltd., has rece... Full Story

GSK Forms Respiratory Disease Big Data Project with Guangzhou Institute

GlaxoSmithKline will form a big data partnership with Guangzhou Institute of Respiratory Diseases (GIRD) to develop a respiratory disease management system that will target both asthma and chronic obstru... Full Story

DelMar Presents Poster of Clinical Research with VAL-083 in Patients with Chemo-resistant Glioblastoma ("GBM") at SNO's Pediatric Neuro-Oncology Basic and Translational Research Conference

, a biopharmaceutical company focused on the development of unique new cancer therapies designed to save and improve lives, announced today the presentation of a poster at The Society for Neuro-Oncology'... Full Story

SihuanPharma Forms China Aesthetic JV with Austria's Croma-Pharma

SihuanPharma formed a JV with Austria's Croma-Pharma to distribute Croma-Pharma's aesthetics products in China. Initially, the JV, SunCro Aesthetics & Cosmetic International, will market Prin... Full Story

Hangzhou's Venus Medtech Acquires InterValve of the US

Venus Medtech of Hangzhou has acquired InterValve, a US maker of transcatheter aortic valve devices, the V8 and TAV8. Venus described the products as the world's pioneering aortic valvuloplasty ballo... Full Story

Athenex, a US-China Cancer Company, Stages $66 Million US IPO

Athenex, a US-China cancer biopharma, completed a $66 million IPO on the NASDAQ exchange. Although that was the low end of the expected range, the company's shares have climbed 24% since they began t... Full Story

Company Search

Upcoming Events More